Related content

Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy

By Okumura Hiroshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 329-334

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Influence of Neoadjuvant Chemoradiation on the Number and Size of Analyzed Lymph Nodes in Esophageal Cancer

By Bollschweiler Elfriede  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3187-3194

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal

By Visser B.C.   Venook A.P.   Patti M.G.  

Surgical Oncology, Vol. 12, Iss. 1, 2003-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy

By McKenzie Shaun  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 551-558

Springer Publishing Company

Access to resources Recommend Favorite